Mukka Proteins Hits All-Time Low Amid Ongoing Financial Struggles and Declining Sales

Mukka Proteins, a microcap player in the FMCG sector, has experienced significant volatility, hitting an all-time low of Rs. 28 today. The stock's performance has been notably poor, with a decline of 1.05% in the last trading session, compared to a 0.60% drop in the Sensex. Over the past week, Mukka Proteins has fallen by 3.96%, and its year-to-date performance shows a decline of 31.40%, contrasting sharply with the Sensex's gain of 3.65%.
The company's financial health raises concerns, highlighted by a high Debt to EBITDA ratio of 4.36 times, indicating challenges in servicing its debt. Mukka Proteins has reported negative results for five consecutive quarters, with net sales declining by 24.57% and profit after tax down by 36.38% over the last nine months. Additionally, institutional investors have reduced their stake by 0.65%, now holding only 3.96% of the company.

Despite a healthy long-term growth rate in operating profit of 50.86%, the overall performance metrics suggest a struggling company facing significant headwinds in both short and long-term profitability.